Biomedicine

Lipopeptide develops products for the treatment of a wide range of wounds, including chronic, non-healing ulcers in skin and mucous membranes.

The intention is to carry the product development at least up to a clinical proof-of-concept, after which a partnership will be established with one or more qualified companies on the wound healing market.